Seminars in Thrombosis and Hemostasis

Article	Citations
	64
	41
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues	41
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	32
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life	31
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice	31
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature	29
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population	28
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants	27
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis	27
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	27
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years	26
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases	26
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy	26
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies	25
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	24
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	24
Platelet Activation and Thrombosis in COVID-19	24
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment	24
Platelet Function Testing: Update and Future Directions	23
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More	22
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient	22
Testing for Lupus Anticoagulants	21
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	21
Fifty Years of Fibrinogen Structure and Function	20

Editorial Compilation—XIII	20
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives	19
Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	19
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	18
The History of Rare Bleeding Disorders	18
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review	17
Cardiovascular Mortality after Venous Thromboembolism: A Meta-Analysis of Prospective Cohort Studies	17
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L	16
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future	15
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice	15
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review	15
Platelet Function: Acute vs. Chronic Responses to Physical Exercise - A Review	15
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	14
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism	14
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase	14
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment	14
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues	14
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III	14
Toward 50 Years of Seminars in Thrombosis and Hemostasis	14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management	14
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System	13
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	13
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?	13
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	13
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	13
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review	12
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu	12
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data	12
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans	12
	12
Automation in Platelet Function Testing: Current Challenges and Future Directions	12
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale	12
	12
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	11
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities	11
Venous Thromboembolism in Children: The Rivaroxaban Experience	11
Colchicine as a Modulator of Platelet Function: A Systematic Review	11
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	11
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic	11
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency	11
	11
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	11
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls	11
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives	11
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy	10
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions	10
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	10
A Historical Perspective on the Reversal of Anticoagulants	10
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review	10

Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome	10
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer	10
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis	10
Editorial Compilation XIV	10
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?	10
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review	10
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis	10
Thrombin Generation Assays: What are the Current Clinical Applications?	9
Bleeding Scoring Systems in Neonates: A Systematic Review	9
	9
	9
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays	9
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass	9
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis	9
Precision Medicine in Rare Bleeding Disorders	9
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions	9
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	9
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia	9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice	9
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	9
Editorial Compilation XI	9
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature	8
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure	8
	8
NETosis in Acute Thrombotic Disorders	8
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	8
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?	8
Platelet Physiology	8
Non-factor Therapies for Hemophilia: Achievements and Perspectives	8
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines	8
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations	8
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	8
Hemostasis Testing in the Emergency Department: A Narrative Review	8
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism	8
One Hundred Years of Congenital Fibrinogen Disorders	7
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke	7
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost	7
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?	7
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	7
	7
Crucial Stepping Stones in Platelet History	7
The More Recent History of Hemophilia Treatment	7
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment	7
PFA-100 System: A New Method for Assessment of Platelet Dysfunction	7
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care	7
Internal Quality Control in Hemostasis Assays	7
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality	7
The Role of Platelets in Atherosclerosis: A Historical Review	7
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives	7
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?	7
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies	6
Evolution of Antiphospholipid Syndrome	6
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond	6
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency	6
Cellular Components Contributing to the Development of Venous Thrombosis in Patients with Pancreatic Cancer	6
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study	6
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	6
	6
Clinical, Laboratory Aspects and Management of Factor X Deficiency	6
Hereditary Angioedema: The Clinical Picture of Excessive Contact Activation	6
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation	6
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000	6
Nebulized Heparin in 2025: at the Interface between Promising Benefits and the Need for Further Research	6
Next-Generation Sequencing and Emerging Technologies*	6
	6
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up	6
Antiplatelet Therapy in Coronary Artery Disease: Now and Then	6
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics	6
Impact of Viral Infections on the Hemostatic System	5
Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature	5
Thrombosis Risk Assessment in Myeloproliferative Neoplasm—Is There a Role for Viscoelastic Testing?	5
Welcome to Seminars in Thrombosis & Hemostasis 2022	5
Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessmen	5
The Pitfalls of Global Hemostasis Assays in Myeloproliferative Neoplasms and Future Challenges	5
	5
Unlocking the Potential of MicroRNA Expression: Biomarkers for Platelet Reactivity and Coronary Artery Disease	5
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific Experience	5
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties	5
A Novel Variant on the Thrombospondin Type-1 Repeat 2 Domain of ADAMTS13 in a Parturient with Suspected Hereditary Thrombotic Thrombocytopenic Purpura and Unusually High ADAMTS13 Activity	5

Monitoring Hemostatic Function during Cardiac Surgery with Point-of-Care Viscoelastic Assays: A Narrative Review	5
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	5
Congenital Bleeding Disorders and COVID-19—A Systematic Literature Review	5
Deep Vein Thrombosis in Adults with HIV: A Systematic Review and Meta-analysis of Prevalence and Risk Factors	5
Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome	5
Laboratory Evaluation of Antithrombin, Protein C, and Protein S	5
Plasma Kallikrein as a Forgotten Clotting Factor	5
2023 Eberhard F. Mammen Award Announcements: Part II–Young Investigator Awards	5
Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients	5
Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review	5
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial	5
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes	5
Platelet Function in Acute Kidney Injury: A Systematic Review and a Cohort Study	5
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	4
Platelets: Physiology and Biochemistry	4
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	4
Causal Relationships of Circulating Inflammatory Proteins and Portal Vein Thrombosis: A Mendelian Randomization Study	4
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	4
Editorial Compilation XII	4
Laser-Induced Blood Coagulation for Surgical Application: A Scoping Review	4
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review	4
What Role Does Microthrombosis Play in Long COVID?	4
Vascular Pathogenesis in Acute and Long COVID: Current Insights and Therapeutic Outlook	4
Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retr	4
Red Blood Cells and Tranexamic Acid in the Inhibition of Fibrinolysis	4
A Critical Reappraisal of the Bleeding Time	4
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review	4
Viscoelastic Testing in the Clinical Management of Subarachnoid Hemorrhage and Intracerebral Hemorrhage	4
Editorial Compilation—XV	4
Viscoelastic Hemostatic Assays in Sepsis: From Pathophysiology to Potential Clinical Implications	4
PKC-Delta-Dependent Pathways Contribute to the Exacerbation of the Platelet Activity in Crohn's Disease	4
Detecting Oxygenator Thrombosis in ECMO: A Review of Current Techniques and an Exploration of Future Directions	4
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	4
Human Genetic Variation in F3 and Its Impact on Tissue Factor–Dependent Disease	4
Has “D-Dimeritis” Worsened during the Coronavirus Disease 2019 Pandemic?	4
Is Vitamin D Deficiency Prothrombotic? A Systematic Review	4
Classification Criteria for the Antiphospholipid Syndrome: Not the Same as Diagnostic Criteria for Antiphospholipid Syndrome	4
Measuring Quality of Life after Venous Thromboembolism: Who, When, and How?	4
Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review	4
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	4
Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease: Comment on “Cancers in Patients with von Willebrand Disease”	4
Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes	4
Antiphospholipid Antibodies in Pregnancy: Maternal and Neonatal Implications	4
Reviewing the Rich History of Fibrin Clot Research with a Focus on Clinical Relevance	4
Platelets in Vascular Calcification: A Comprehensive Review of Platelet-Derived Extracellular Vesicles, Protein Interactions, Platelet Function Indices, and their Impact on Cellular Crosstalk	4
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	4
Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies	3
Hereditary Angioedema and Venous Thromboembolism: Where There's Smoke, There's Fire	3
Optimizing and Extending the Risk-Adapted Management of Acute Pulmonary Embolism beyond the Acute Phase: Progress in Pulmonary Embolism Research	3
Ischemic Stroke in Cancer: Mechanisms, Biomarkers, and Implications for Treatment	3
New Insights in Coagulation and Fibrinolysis in Patients with Primary Brain Cancer: A Systematic Review	3
Evolution of Hemostasis Testing: A Personal Reflection Covering over 40 Years of History*	3
	3
Post COVID-19 Large Vessel Vasculopathy in a Previously Healthy Young Male	3
Pearls and Pitfalls in the Measurement of Direct Oral Anticoagulants	3
The ABO Blood System and Associated Implications for Hemostasis and Thrombosis	3
Hemostasis, Thrombosis, and Vascular Biology in Psychiatric Disorders	3
Comparative Analysis of Four Risk Stratification Models to Identify Patients with Acute Pulmonary Embolism at Risk of Short-term Mortality	3
Hemostatic and Inflammatory Biomarkers are Associated with Functional Limitations after Venous Thromboembolism: A Prospective Cohort Study	3
Risk Factors of Catheter-Related Thrombosis in Elderly Patients with Lung Cancer Based on Thromboelastography: A Retrospective, Case-Control Study	3
Prediction of Recurrent Venous Thromboembolism and Arterial Cardiovascular Events after Discontinuation of Anticoagulation: The R-VTE-predict and MACE-predict Risk Scores	3
Prone Position and the Risk of Venous Thrombosis in COVID-19 Patients with Respiratory Failure	3
	3
Platelet Contributions to the (Pre)metastatic Tumor Microenvironment	3
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	3
Diagnosis and Treatment of Autoimmune Acquired Coagulation Factor Deficiencies: An Evidence-Based Review of Japanese Practice	3
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience	3
Role of Viscoelastic and Conventional Coagulation Tests for Management of Blood Product Replacement in the Bleeding Patient	3
New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia	3
Antiphospholipid Antibodies in Mental Disorders	3
COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT) and the Shades of Grey in Thrombus Formation	3
Red Blood Cells are Critical for Hemostasis and Thrombosis	3
Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis	3
Stability of Hemostasis Parameters in Whole Blood, Plasma, and Frozen Plasma: Literature Review and Recommendations of the SFTH (French Society of Thrombosis and Haemostasis)	3
The Bleeding Time Test in 2024: A Glorious Past and Current Challenges	3
	3
Prophylaxis of Venous Thromboembolism in Children: A Systematic Review	3
The Evolution of Hemophilia Pharmacological Treatments and Therapeutic Targets at the Turn of the Third Millennium	3
Coronary Thrombosis with Distal Embolization in a Young Patient after Orthopaedic Surgery: An Informative Case Report	3
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	3
Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis	3
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	3
Heparins May Not Be the Optimal Anticoagulants for Sepsis and Sepsis-Associated Disseminated Intravascular Coagulation	3
Neutrophil-Mediated Effects on Hemostasis and Thrombosis: Unraveling Their Complex Interaction in Thrombotic Events	3
	2
Gastrointestinal Bleeding in Congenital Bleeding Disorders	2
Erratum: Septic Pulmonary Embolism. A Contemporary Profile	2
Heparin: The Journey from Parenteral Agent to Nasal Delivery	2
	2
	2
Recent Advances in Thrombosis and Hemostasis—Part VII	2
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	2
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade	2
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	2
Blood Rheology and Hemodynamics: Still Illuminating after 20 Years	2